Dehghanbanadaki Hojat, Fahimfar Noushin, Aazami Hossein, Mansourzadeh Mohammad Javad, Noorali Sima, Yarmohammadi Hossein, Hajivalizadeh Sepideh, Sanjari Mahnaz, Khalagi Kazem, Larijani Bagher, Ostovar Afshin
Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
J Diabetes Metab Disord. 2023 Dec 7;23(1):699-708. doi: 10.1007/s40200-023-01338-7. eCollection 2024 Jun.
Trabecular bone score (TBS), as a texture indicator of bone microarchitecture, predicts the risk of fracture. This study aims to explore the knowledge map of TBS.
We searched Scopus for "trabecular bone score" or "trabecular score" from the beginning to 2021. Our inclusion criteria were original articles and reviews that were related to TBS and our exclusion criteria were non-English articles, non-related to TBS, and document type other than original articles and reviews. and related documents were included for bibliometric analysis. Excel, VOS viewer, and Science of Science (Sci2) software were used for data synthesis.
From 749 retrieved articles, 652 articles were included for analysis. These documents were cited 12,153 times and had an H-index of 56. The most productivity belonged to the USA (n = 130 documents), Switzerland (n = 101), and Italy (n = 67). "Osteoporosis International" (n = 80) had the highest participation in publishing. The research topics of interest were mainly related to the applicability of TBS for fracture risk assessment in chronic endocrine disorders such as osteoporosis and diabetes mellitus. Bursting analysis of the title and abstract revealed the initial focus of the discriminative power of TBS for osteoporotic fracture and the more recent focus on comparing bone mineral density (BMD) and TBS in a variety of chronic diseases.
The number of annual publications on TBS has increased, especially after 2016. These publications highlight the importance of in-depth knowledge of TBS in predicting fracture risk and also its strengths and limitations of treatment monitoring in different health conditions.
The online version contains supplementary material available at 10.1007/s40200-023-01338-7.
骨小梁骨评分(TBS)作为骨微结构的纹理指标,可预测骨折风险。本研究旨在探索TBS的知识图谱。
我们在Scopus数据库中检索了从开始到2021年期间的“骨小梁骨评分”或“骨小梁评分”。我们的纳入标准是与TBS相关的原创文章和综述,排除标准是非英文文章、与TBS无关的文章以及原创文章和综述以外的文献类型。纳入相关文献进行文献计量分析。使用Excel、VOS viewer和科学学(Sci2)软件进行数据合成。
从检索到的749篇文章中,纳入652篇进行分析。这些文献被引用12153次,H指数为56。发文量最多的是美国(n = 130篇文献)、瑞士(n = 101篇)和意大利(n = 67篇)。《骨质疏松国际》(n = 80篇)在发表方面的参与度最高。感兴趣的研究主题主要与TBS在骨质疏松症和糖尿病等慢性内分泌疾病骨折风险评估中的适用性有关。对标题和摘要的突发分析显示,最初关注的是TBS对骨质疏松性骨折的判别能力,最近则关注在各种慢性疾病中比较骨密度(BMD)和TBS。
关于TBS的年度发表数量有所增加,尤其是在2016年之后。这些发表突出了深入了解TBS在预测骨折风险方面的重要性,以及其在不同健康状况下治疗监测的优势和局限性。
在线版本包含可在10.1007/s40200-023-01338-7获取的补充材料。